Leukotrienes and Lung Inflammation

白三烯与肺部炎症

基本信息

  • 批准号:
    7269573
  • 负责人:
  • 金额:
    $ 42.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-04-04 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mast cells, macrophages, and polymorphonuclear leukocytes (PMN), initiate and amplify inflammation in the lung by synthesizing and releasing the bioactive lipids leukotriene (LT)B4, and LTC4. After its release from cells, LTC4 is converted to LTD4. These eicosanoids help "shape" the pulmonary inflammatory response by regulating leukocyte recruitment, endothelial permeability, fibroblast proliferation, and smooth muscle contraction. LTC4, LTD4 and LTB4 are central to the pathogenesis of asthma and idiopathic pulmonary fibrosis (IFF). They are also critical for host defense to infection. How cells modulate the synthesis of these eicosanoids is therefore central to the pathogenesis of these diseases. The formation of LTC4 requires the functional interaction of at least four proteins on the nuclear envelope. These are cytosolic phospholipase A2 (cPLA2), 5-lipoxygenase (5-LO), the 5-lipoxygenase-activating protein (FLAP), and LTC4 synthase; the metabolism of LTA by LTA4 hydrolase yields LTB4. We have used a combination of biochemistry and molecular imaging to demonstrate the interaction of 5-LO, FLAP, and LTC4 synthase in novel, activation- dependent, macromolecular complexes on the nuclear envelope that include additional proteins. We have also identified a 10 kDa protein (Associated Protein 10 kDa, AP-10) that dissociates from FLAP after cell activation concurrent with complex formation. The hypothesis of this proposal is that these complexes are the link between cell activation and LT synthesis. The broad long-term objective of this proposal is to understand how the assembly, degradation, and compartmentalization of these complexes regulate the formation of LTs on molecular, cell biological, and in vivo levels. Three Specific Aims are proposed. In Specific Aim 1 we will determine how 5-LO membrane complexes are assembled and organized. In Specific Aim 2 we will identify the AP-10 protein. In Specific Aim 3 we will test the hypothesis that the synthesis of LTC4 and LTB4 is compartmentalized between the cytosol and nucleus and that newly identified inner membrane 5-LO complexes regulate the synthesis of LTB4. The completion of these aims will allow the identification of novel mechanisms and, potentially, therapeutic approaches, to inflammatory pulmonary diseases.
描述(由申请人提供):肥大细胞、巨噬细胞和多形核白细胞(PMN),通过合成和释放生物活性脂质白三烯(LT)B4和LTC4来启动和放大肺部炎症。从细胞中释放出来后,LTC4转化为LTD4。这些类二十烷酸通过调节白细胞募集、内皮细胞渗透性、成纤维细胞增殖和平滑肌收缩来帮助“塑造”肺部炎症反应。LTC4、LTD4和LTB4是哮喘和特发性肺纤维化(IFF)发病机制的核心。它们对宿主防御感染也至关重要。因此,细胞如何调节这些类二十烷醇的合成是这些疾病发病机制的核心。LTC4的形成需要核膜上至少四种蛋白的功能性相互作用。它们是胞质磷脂酶A2 (cPLA2)、5-脂氧合酶(5-LO)、5-脂氧合酶激活蛋白(FLAP)和LTC4合成酶;LTA4水解酶代谢LTA生成LTB4。我们使用生物化学和分子成像相结合的方法来证明5-LO、FLAP和LTC4合成酶在核膜上包含额外蛋白质的新型、依赖激活的大分子复合物中的相互作用。我们还发现了一个10 kDa的蛋白(Associated protein 10 kDa, AP-10),在细胞激活和复合物形成后从FLAP中分离。该建议的假设是这些复合物是细胞活化和LT合成之间的联系。本研究的长期目标是了解这些复合物的组装、降解和区区化如何在分子、细胞生物学和体内水平上调节LTs的形成。提出了三个具体目标。在Specific Aim 1中,我们将确定5-LO膜复合物是如何组装和组织的。在特异性目标2中,我们将鉴定AP-10蛋白。在Specific Aim 3中,我们将验证LTC4和LTB4的合成在细胞质和细胞核之间划分的假设,以及新发现的内膜5-LO复合物调节LTB4的合成。这些目标的完成将有助于确定炎症性肺病的新机制和潜在的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Roy Soberman其他文献

Roy Soberman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Roy Soberman', 18)}}的其他基金

A System for FLIM Microscopy
FLIM 显微镜系统
  • 批准号:
    7796944
  • 财政年份:
    2010
  • 资助金额:
    $ 42.68万
  • 项目类别:
Leukotrienes and Lung Inflammation
白三烯与肺部炎症
  • 批准号:
    8091986
  • 财政年份:
    2010
  • 资助金额:
    $ 42.68万
  • 项目类别:
Leukotrienes and Lung Inflammation
白三烯与肺部炎症
  • 批准号:
    7392805
  • 财政年份:
    2007
  • 资助金额:
    $ 42.68万
  • 项目类别:
Leukotrienes and Lung Inflammation
白三烯与肺部炎症
  • 批准号:
    7778182
  • 财政年份:
    2007
  • 资助金额:
    $ 42.68万
  • 项目类别:
Leukotrienes and Lung Inflammation
白三烯与肺部炎症
  • 批准号:
    8041025
  • 财政年份:
    2007
  • 资助金额:
    $ 42.68万
  • 项目类别:
Leukotrienes and Lung Inflammation
白三烯与肺部炎症
  • 批准号:
    7623851
  • 财政年份:
    2007
  • 资助金额:
    $ 42.68万
  • 项目类别:
Leukotrienes and Lung Inflammation
白三烯与肺部炎症
  • 批准号:
    7186320
  • 财政年份:
    2006
  • 资助金额:
    $ 42.68万
  • 项目类别:
Role of B7-1 in Podocytes in Pathogenesis of Proteinuria
足细胞 B7-1 在蛋白尿发病机制中的作用
  • 批准号:
    9322522
  • 财政年份:
    2004
  • 资助金额:
    $ 42.68万
  • 项目类别:
Role of B7-1 in Podocytes in Pathogenesis of Proteinuria
足细胞 B7-1 在蛋白尿发病机制中的作用
  • 批准号:
    8895921
  • 财政年份:
    2004
  • 资助金额:
    $ 42.68万
  • 项目类别:
PHARMACOLOGY OF 4F CYTOCHROME P450'S
4F 细胞色素 P450 的药理学
  • 批准号:
    6387236
  • 财政年份:
    2000
  • 资助金额:
    $ 42.68万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.68万
  • 项目类别:
    Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 42.68万
  • 项目类别:
    Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 42.68万
  • 项目类别:
    Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 42.68万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 42.68万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 42.68万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 42.68万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 42.68万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 42.68万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 42.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了